A four-in-one pure nanomedicine for synergistic multi-target therapy against breast cancer-Reference-Cited by-同舟云学术

A four-in-one pure nanomedicine for synergistic multi-target therapy against breast cancer

Published:2021 Issue:42 Volume:9 Page:8809-8822
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Zhang Rui¹,Cheng Ge¹,Liu Shengnan²,Lv Hongying³,Li Juan¹^ORCID

Affiliation:

1. School of Public Health, Jilin University, Changchun, 130021, Jilin, China

2. China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, China

3. Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Radiation Medicine Chinese Academy of Medical Sciences, Institute of Radiation Medicine, Tianjin, 300192, China

Abstract

Novel four-in-one RRX/BMS/CA4/PTX NPs were used to target tumour cells, MDSCs, CSCs, PD-L1 and tumour microvessels for multi-target therapy of tumour.

Funder

Department of Science and Technology of Jilin Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2021/TB/D1TB01820E

Reference52 articles.

1. Drug repurposing for breast cancer therapy: Old weapon for new battle

2. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

3. Diverse Distribution and Gene Expression on the 21-Gene Recurrence Assay in Breast Cancer Patients with Locoregional Recurrence Versus Distant Metastasis

4. Self‐Assembled/Drug‐Composed Nanomedicine for Synergistic Photonic Hyperthermia and Targeted Therapy of Breast Cancer by Inhibiting ERK, AKT, and STAT3 Signaling Cascades

5. Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer;Frontiers in Oncology;2024-05-02

2. Nanomedicine Targeting Myeloid‐Derived Suppressor Cells Enhances Anti‐Tumor Immunity;Advanced Healthcare Materials;2024-02-11

3. Assembling Au8 clusters on surfaces of bifunctional nanoimmunomodulators for synergistically enhanced low dose radiotherapy of metastatic tumor;Journal of Nanobiotechnology;2024-01-05

4. Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy;Chinese Chemical Letters;2023-08